Glycaemic variability in diabetes: clinical and therapeutic implications

Antonio Ceriello, Louis Monnier, David Owens

Research output: Contribution to journalReview article

Abstract

Glycaemic variability is an integral component of glucose homoeostasis. Although it has not yet been definitively confirmed as an independent risk factor for diabetes complications, glycaemic variability can represent the presence of excess glycaemic excursions and, consequently, the risk of hyperglycaemia or hypoglycaemia. Glycaemic variability is currently defined by a large and increasing number of metrics, representing either short-term (within-day and between-day variability) or long-term glycaemic variability, which is usually based on serial measurements of HbA1c or other measures of glycaemia over a longer period of time. In this Review, we discuss recent evidence examining the association between glycaemic variability and diabetes-related complications, as well as non-pharmacological and pharmacological strategies currently available to address this challenging aspect of diabetes management.

Original languageEnglish
JournalThe Lancet Diabetes and Endocrinology
DOIs
Publication statusE-pub ahead of print - Aug 13 2018

Fingerprint

Diabetes Complications
Hypoglycemia
Hyperglycemia
Homeostasis
Pharmacology
Glucose
Therapeutics

Cite this

Glycaemic variability in diabetes : clinical and therapeutic implications. / Ceriello, Antonio; Monnier, Louis; Owens, David.

In: The Lancet Diabetes and Endocrinology, 13.08.2018.

Research output: Contribution to journalReview article

@article{c512076193a2458aaade9c8283192582,
title = "Glycaemic variability in diabetes: clinical and therapeutic implications",
abstract = "Glycaemic variability is an integral component of glucose homoeostasis. Although it has not yet been definitively confirmed as an independent risk factor for diabetes complications, glycaemic variability can represent the presence of excess glycaemic excursions and, consequently, the risk of hyperglycaemia or hypoglycaemia. Glycaemic variability is currently defined by a large and increasing number of metrics, representing either short-term (within-day and between-day variability) or long-term glycaemic variability, which is usually based on serial measurements of HbA1c or other measures of glycaemia over a longer period of time. In this Review, we discuss recent evidence examining the association between glycaemic variability and diabetes-related complications, as well as non-pharmacological and pharmacological strategies currently available to address this challenging aspect of diabetes management.",
author = "Antonio Ceriello and Louis Monnier and David Owens",
note = "Copyright {\circledC} 2018 Elsevier Ltd. All rights reserved.",
year = "2018",
month = "8",
day = "13",
doi = "10.1016/S2213-8587(18)30136-0",
language = "English",
journal = "The Lancet Diabetes and Endocrinology",
issn = "2213-8587",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Glycaemic variability in diabetes

T2 - clinical and therapeutic implications

AU - Ceriello, Antonio

AU - Monnier, Louis

AU - Owens, David

N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.

PY - 2018/8/13

Y1 - 2018/8/13

N2 - Glycaemic variability is an integral component of glucose homoeostasis. Although it has not yet been definitively confirmed as an independent risk factor for diabetes complications, glycaemic variability can represent the presence of excess glycaemic excursions and, consequently, the risk of hyperglycaemia or hypoglycaemia. Glycaemic variability is currently defined by a large and increasing number of metrics, representing either short-term (within-day and between-day variability) or long-term glycaemic variability, which is usually based on serial measurements of HbA1c or other measures of glycaemia over a longer period of time. In this Review, we discuss recent evidence examining the association between glycaemic variability and diabetes-related complications, as well as non-pharmacological and pharmacological strategies currently available to address this challenging aspect of diabetes management.

AB - Glycaemic variability is an integral component of glucose homoeostasis. Although it has not yet been definitively confirmed as an independent risk factor for diabetes complications, glycaemic variability can represent the presence of excess glycaemic excursions and, consequently, the risk of hyperglycaemia or hypoglycaemia. Glycaemic variability is currently defined by a large and increasing number of metrics, representing either short-term (within-day and between-day variability) or long-term glycaemic variability, which is usually based on serial measurements of HbA1c or other measures of glycaemia over a longer period of time. In this Review, we discuss recent evidence examining the association between glycaemic variability and diabetes-related complications, as well as non-pharmacological and pharmacological strategies currently available to address this challenging aspect of diabetes management.

U2 - 10.1016/S2213-8587(18)30136-0

DO - 10.1016/S2213-8587(18)30136-0

M3 - Review article

C2 - 30115599

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

SN - 2213-8587

ER -